Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
Multidisciplinary management of multiple sclerosis symptoms.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Multiple sclerosis: from molecules to treatment.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
RORs in Autoimmune Disease.
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go.
Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Examining multiple sclerosis through the eyes of a child.
Pages
« first
‹ previous
…
328
329
330
331
332
333
334
335
336
…
next ›
last »